Medical Trial Guidance Scrubbed

Another detail out of FDA. The agency has removed pages which provide guidance to medical researchers on conducting medical trials with representative numbers of men and women and ethnic and/or racial minority groups. I think most people know this: but this isn’t a matter of symbolic diversity. Many medications and/or diseases or conditions present differently in men and woman and in people with different genetic backgrounds.